- Home
- PROK vs JOF Comparison
PROK vs JOF Comparison
Compare PROK & JOF Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- PROK
- JOF
- Stock Information
- Founded
- PROK 2015
- JOF 1990
- Country
- PROK United States
- JOF Japan
- Employees
- PROK N/A
- JOF N/A
- Industry
- PROK Biotechnology: Biological Products (No Diagnostic Substances)
- JOF Trusts Except Educational Religious and Charitable
- Sector
- PROK Health Care
- JOF Finance
- Exchange
- PROK Nasdaq
- JOF Nasdaq
- Market Cap
- PROK 211.1M
- JOF 220.2M
- IPO Year
- PROK N/A
- JOF N/A
- Fundamental
- Price
- PROK $1.63
- JOF $7.65
- Analyst Decision
- PROK Buy
- JOF
- Analyst Count
- PROK 5
- JOF 0
- Target Price
- PROK $4.50
- JOF N/A
- AVG Volume (30 Days)
- PROK 409.2K
- JOF 43.9K
- Earning Date
- PROK 03-21-2025
- JOF 01-01-0001
- Dividend Yield
- PROK N/A
- JOF 3.33%
- EPS Growth
- PROK N/A
- JOF N/A
- EPS
- PROK N/A
- JOF N/A
- Revenue
- PROK N/A
- JOF N/A
- Revenue This Year
- PROK N/A
- JOF N/A
- Revenue Next Year
- PROK N/A
- JOF N/A
- P/E Ratio
- PROK N/A
- JOF N/A
- Revenue Growth
- PROK N/A
- JOF N/A
- 52 Week Low
- PROK $1.18
- JOF $6.64
- 52 Week High
- PROK $4.44
- JOF $8.04
- Technical
- Relative Strength Index (RSI)
- PROK 46.75
- JOF 51.62
- Support Level
- PROK $1.57
- JOF $7.63
- Resistance Level
- PROK $1.77
- JOF $7.82
- Average True Range (ATR)
- PROK 0.12
- JOF 0.12
- MACD
- PROK -0.00
- JOF 0.01
- Stochastic Oscillator
- PROK 39.06
- JOF 64.47
About PROK ProKidney Corp.
ProKidney Corp is a clinical-stage biotechnology company with a transformative proprietary cell therapy platform capable of treating multiple chronic kidney diseases using a patient's own cells isolated from the patient intended for treatment. Its lead product candidate, REACT (Renal Autologous Cell Therapy) is a disease-modifying cell therapy made from a patient's own renal cells. REACT has the potential to slow and stabilize the progression of chronic kidney disease. The company's pipeline consists of development program for severe diabetic kidney disease.
About JOF Japan Smaller Capitalization Fund Inc
Japan Smaller Capitalization Fund Inc is a United States-based non-diversified, closed-end management investment company. Its investment objective is to seek long-term capital appreciation through investments in smaller capitalization Japanese equity securities. Its portfolio of investments consists of different sectors such as banks, chemicals, construction, electric appliances, financing business, food, Information and Communication, Utilities, Real Estate, and others.